Leesa Gentry - Apr 14, 2025 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role: Chief Clinical Officer
Signature: /s/ Leesa Gentry
Stock symbol: RNXT
Transactions as of: Apr 14, 2025
Transactions value $: $0
Form type: 4
Date filed: 4/16/2025, 05:18 PM
Previous filing: Mar 8, 2024
Next filing: Jul 3, 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RNXT	Stock Option	Award	$0	+26.5K		$0.00	26.5K	Apr 14, 2025	Common Stock	26.5K	$0.84	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 26,477 shares of the Issuer's common stock (7,173 shares of which are underlying incentive stock options and 19,304 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035.

Content

On April 14, 2025, with the approval of the Compensation Committee of the Issuer's Board of Directors, the Reporting Person was granted stock options to purchase up to 26,477 shares of the Issuer's common stock (7,173 shares of which are underlying incentive stock options and 19,304 of which are underlying non-qualified stock options), with such options vesting over four years at a rate of 1/48 per month with no cliff, and with vesting commencing effective January 1, 2025. The options will only become exercisable when there is an effective registration statement covering the shares underlying the options. The options will become fully vested on January 1, 2029, and will expire on April 14, 2035.